DEPUY WARSAW

Manufacturer adverse-event records for DEPUY WARSAW come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2009–2013 · mid-book · typical Death-code · injury-heavy

Injury-mix signature

DEPUY WARSAW leans injury-heavy in event_type mix

Injury-coded event_type share is 97.8% (injury-heavy tercile) beside 0.08% Death-coded (typical). Volume band: mid.

What the Injury-mix reading shows for DEPUY WARSAW

The standout signal for DEPUY WARSAW is Injury-mix: 97.8% Injury-coded (injury-heavy) beside 0.08% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for DEPUY WARSAW. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Injury at 7,365 (97.8% of event_type total). Peak single-year volume reaches 5,251 reports across 5 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

7,534
Total Reports
6
Event-type Death
7,365
Injury Reports
20
Device Types

Event Types

Injury 7,365 (97.8%)
Malfunction 161 (2.1%)
Death 6 (0.1%)
2 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 7,148 (94.8%)
Other 210 (2.8%)
169 (2.2%)
R 9 (0.1%)
Death 6 (0.1%)
Congenital Anomaly 1 (0.0%)

Yearly Trend

09
2009: 1
10
2010: 2
11
2011: 2,131
12
2012: 5,251
13
2013: 149